Yukio Nakamura

Researcher Name Resolver ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Topics

Venous Thromboembolism

Duchenne Muscular Dystrophy

Postmenopausal Women

Top Venues

Journal of bone and mineral metabolism

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Takashige Momose, Masaki Nakano, Yukio Nakamura, Takashi Maeda, Masashi Nawata
Incidence and preventive treatment for deep vein thrombosis with our own preventive protocol in total hip and knee arthroplasty. PloS one 19 (1) (2024)
Takashige Momose, Masaki Nakano, Yukio Nakamura, Takashi Maeda, Masashi Nawata
Incidence and preventive treatment for deep vein thrombosis with our own preventive protocol in total hip and knee arthroplasty. PloS one 19 (1) (2024)
Masaki Nakano, Kazuhiro Uenishi, Yukio Nakamura, Jun Takahashi, Masataka Shiraki
Distinct dietary risk factors for incident osteoporotic fractures in early and late postmenopausal phase women. Journal of bone and mineral metabolism 41 (2) (2023)
Masaki Nakano, Kazuhiro Uenishi, Yukio Nakamura, Jun Takahashi, Masataka Shiraki
Distinct dietary risk factors for incident osteoporotic fractures in early and late postmenopausal phase women. Journal of bone and mineral metabolism (2023)
Takashi Maeda, Masaki Nakano, Yukio Nakamura, Takashige Momose, Atsushi Sobajima, Jun Takahashi, Katsuya Nakata, Masashi Nawata
Relationship between Stress Shielding and Optimal Femoral Canal Contact Regions for Short, Tapered-Wedge Stem Analyzed by 2D and 3D Systems in Total Hip Arthroplasty. Journal of clinical medicine 12 (9) (2023)
Takashi Maeda, Masaki Nakano, Yukio Nakamura, Takashige Momose, Atsushi Sobajima, Jun Takahashi, Katsuya Nakata, Masashi Nawata
Relationship between Stress Shielding and Optimal Femoral Canal Contact Regions for Short, Tapered-Wedge Stem Analyzed by 2D and 3D Systems in Total Hip Arthroplasty. Journal of clinical medicine 12 (9) (2023)
Masataka Shiraki, Tatsuhiko Kuroda, Masaki Nakano, Yukio Nakamura, Mitsuru Saito, Tomohiko Urano
Nitric oxide is associated with fracture risk in Japanese women. PloS one 18 (2) (2023)
Masaki Nakano, Kazuhiro Uenishi, Yukio Nakamura, Jun Takahashi, Masataka Shiraki
Distinct dietary risk factors for incident osteoporotic fractures in early and late postmenopausal phase women. Journal of bone and mineral metabolism 41 (2) (2023)
Masaki Nakano, Kazuhiro Uenishi, Yukio Nakamura, Jun Takahashi, Masataka Shiraki
Distinct dietary risk factors for incident osteoporotic fractures in early and late postmenopausal phase women. Journal of bone and mineral metabolism 41 (2) (2023)
Masataka Shiraki, Tatsuhiko Kuroda, Masaki Nakano, Yukio Nakamura, Mitsuru Saito, Tomohiko Urano
Nitric oxide is associated with fracture risk in Japanese women. PloS one 18 (2) (2023)
Masataka Shiraki, Tatsuhiko Kuroda, Masaki Nakano, Yukio Nakamura, Mitsuru Saito, Tomohiko Urano
Nitric oxide is associated with fracture risk in Japanese women. PloS one 18 (2) (2023)
Masaki Nakano, Yukio Nakamura, Akiko Miyazaki, Jun Takahashi
Zinc Pharmacotherapy for Elderly Osteoporotic Patients with Zinc Deficiency in a Clinical Setting. Nutrients 13 (6) (2021)
Kohei Murakami, Shingo Kikugawa, Shoji Seki, Hidetomi Terai, Takako Suzuki, Masaki Nakano, Jun Takahashi, Yukio Nakamura
Exome Sequencing Reveals De Novo Variants in Congenital Scoliosis. Journal of pediatric genetics 11 (4) (2021)
Daiki Kumaki, Yukio Nakamura, Noriko Sakai, Tomoki Kosho, Akinori Nakamura, Shinichi Hirabayashi, Takako Suzuki, Mikio Kamimura, Hiroyuki Kato
Efficacy of Denosumab for Glucocorticoid-Induced Osteoporosis in an Adolescent Patient with Duchenne Muscular Dystrophy: A Case Report. JBJS case connector 8 (2) (2019)
Daiki Kumaki, Yukio Nakamura, Takako Suzuki, Hiroyuki Kato
Efficacy of Denosumab for Osteoporosis in Two Patients with Adult-Onset Still's Disease-Denosumab Efficacy in Osteoporotic Still's Disease Patients. Journal of clinical medicine 7 (4) (2018)
Kohei Murakami, Yasuhiro Kobayashi, Shunsuke Uehara, Takako Suzuki, Masanori Koide, Teruhito Yamashita, Midori Nakamura, Naoyuki Takahashi, Hiroyuki Kato, Nobuyuki Udagawa, Yukio Nakamura
A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitro. PloS one 12 (7) (2017)